Regulatory RNA

Advertisement

cGxPJobs Banner

CAMP4 Therapeutics Prepares CMP-002 Phase 1/2 Trial for SYNGAP1

WATERTOWN, Mass. — September 8, 2026 CAMP4 Therapeutics Corporation announced plans to host a virtual Analyst Day on September...

By cGxPwire Editor
September 10, 2026

Read More

Advertisement

cGxPJobs

Directory